Cargando…

Immune-infiltrating signature-based classification reveals CD103(+)CD39(+) T cells associate with colorectal cancer prognosis and response to immunotherapy

BACKGROUND: Current stratification systems for tumor prognostic prediction and immunotherapeutic efficacy evaluation are less satisfying in colorectal cancer (CRC). As infiltrating immune cells in tumor microenvironment (TME) played a key role in tumor progression and responses to immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yang, Zong, Yunfeng, Hua, Hanju, Gong, Meiting, Peng, Qiao, Li, Chen, Neculai, Dante, Zeng, Xun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596778/ https://www.ncbi.nlm.nih.gov/pubmed/36311750 http://dx.doi.org/10.3389/fimmu.2022.1011590

Ejemplares similares

Infiltration and Significance of CD103+CD8+ T Cells in Gastrointestinal Adenocarcinoma
por: Cai, Weisu, et al.
Publicado: (2022)

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
por: Duhen, Thomas, et al.
Publicado: (2018)

Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer
por: Workel, Hagma H., et al.
Publicado: (2020)

CD103(+) tumor-infiltrating lymphocytes predict favorable prognosis in patients with esophageal squamous cell carcinoma
por: Chu, Yifan, et al.
Publicado: (2019)

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
por: van den Bulk, Jitske, et al.
Publicado: (2023)

CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39
por: Zhang, Xiao, et al.
Publicado: (2019)

CD39/CD73/A2AR pathway and cancer immunotherapy
por: Xia, Chenglai, et al.
Publicado: (2023)

Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided “immune-hot” colorectal cancers
por: Talhouni, Shahd, et al.
Publicado: (2023)

CD103 spurs on suppressors
por: Van Epps, Heather L.
Publicado: (2005)

In lung adenocarcinoma, low expression of the cell surface extracellular nucleotidase CD39 is related to immune infiltration and a poor prognosis
por: Shao, Lili, et al.
Publicado: (2022)

CD103(+) regulatory T cells underlie resistance to radio-immunotherapy and impair CD8(+) T cell activation in glioblastoma
por: van Hooren, Luuk, et al.
Publicado: (2023)

High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma
por: Wu, Jie, et al.
Publicado: (2020)

The expression profiles of signature genes from CD103(+)LAG3(+) tumour-infiltrating lymphocyte subsets predict breast cancer survival
por: Xia, Zi-An, et al.
Publicado: (2023)

CD86 Is Associated with Immune Infiltration and Immunotherapy Signatures in AML and Promotes Its Progression
por: Zhang, Qianqian, et al.
Publicado: (2023)

CD103 in the development of experimental asthma
por: Blanchet, Marie-Renee, et al.
Publicado: (2010)

Development of [(89)Zr]Zr-hCD103.Fab01A and [(68)Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
por: Fan, Xiaoyu, et al.
Publicado: (2023)

Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer
por: Webb, John R, et al.
Publicado: (2014)

Intratumoral CD103(+)CD4(+) T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients
por: Gu, Yun, et al.
Publicado: (2020)

Intestinal CD103(+)CD4(+) and CD103(+)CD8(+) T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up
por: Roosenboom, Britt, et al.
Publicado: (2019)

Prognostic implications of intratumoral CD103(+) tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma
por: Koh, Jaemoon, et al.
Publicado: (2017)

CD38(+)CD39(+) NK cells associate with HIV disease progression and negatively regulate T cell proliferation
por: Qian, Shi, et al.
Publicado: (2022)

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
por: Komdeur, Fenne L., et al.
Publicado: (2017)

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103(+)CD8(+) T cells conferring favourable prognosis
por: Li, Ruochen, et al.
Publicado: (2020)

Accumulation of CD103(+) CD8(+) T cells in a cutaneous melanoma micrometastasis
por: Hochheiser, Katharina, et al.
Publicado: (2019)

TGF-β: Many Paths to CD103(+) CD8 T Cell Residency
por: Qiu, Zhijuan, et al.
Publicado: (2021)

Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer
por: Kol, Arjan, et al.
Publicado: (2021)

Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma
por: Dong, Dan-Ning, et al.
Publicado: (2021)

Comprehensive analyses of a CD8(+) T cell infiltration related gene signature with regard to the prediction of prognosis and immunotherapy response in lung squamous cell carcinoma
por: Chen, Liang, et al.
Publicado: (2023)

The origin and development of nonlymphoid tissue CD103(+) DCs
por: Ginhoux, Florent, et al.
Publicado: (2009)

Pivotal role of CD103 in the development of psoriasiform dermatitis
por: Fukui, Takehito, et al.
Publicado: (2020)

T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1
por: Trad, Malika, et al.
Publicado: (2015)

CD103 Expression Is Required for Destruction of Pancreatic Islet Allografts by CD8(+) T Cells
por: Feng, Ye, et al.
Publicado: (2002)

Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
por: Schäkel, Laura, et al.
Publicado: (2020)

CCR9+ and CD103+ tolerogenic dendritic cell populations in food allergy patients undergoing oral immunotherapy
por: Garcia, Marco, et al.
Publicado: (2011)

PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1(hi)CD39(+) CD4 T cells
por: Balança, Camille-Charlotte, et al.
Publicado: (2021)

CD39(+) conventional CD4(+) T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade
por: Bossio, Sabrina N., et al.
Publicado: (2023)

CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC
por: Sanders, Christine, et al.
Publicado: (2022)

TLR3 Activation of Intratumoral CD103(+) Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity
por: Roselli, Emiliano, et al.
Publicado: (2019)

Development of (89)Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration
por: Kol, Arjan, et al.
Publicado: (2022)

Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival
por: Vlaming, Martijn, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_av9orfk350t60vm6vu1utmc0uc